UMIN000049680
Future prospects for therapeutic strategies for brain metastases and acquired resistance in the treatment of ALK positive advanced non small cell lung cancer. A comprehensive literature review with network meta-analysis.
Showa University school of medicine·University Hospital Medical Information NetworkCompleted
Study focus
- Disease/Condition
- Non-small cell lung cancer
Sponsor & location
- Primary sponsor
- Showa University school of medicine
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Dec 03, 2022
- End date
- N/A
ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000049680
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000049680 through Pure Global AI's free database. This phase not specified trial is sponsored by Showa University school of medicine and is currently Completed. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.